Jessen, F., Arbizu, J., Boada, M., Balasa, M., Bennys, K., Boban, M., . . . Winblad, B. (2025). Comment by European Alzheimer’s Disease Consortium (EADC) investigators on the negative recommendation of the CHMP on the marketing authorization of donanemab for early Alzheimer’ s disease. Letter to the editor. The journal of prevention of Alzheimer's disease, 12(8), . https://doi.org/10.1016/j.tjpad.2025.100259
Chicago-Zitierstil (17. Ausg.)Jessen, Frank, et al. "Comment by European Alzheimer’s Disease Consortium (EADC) Investigators on the Negative Recommendation of the CHMP on the Marketing Authorization of Donanemab for Early Alzheimer’ S Disease. Letter to the Editor." The Journal of Prevention of Alzheimer's Disease 12, no. 8 (2025). https://doi.org/10.1016/j.tjpad.2025.100259.
MLA-Zitierstil (9. Ausg.)Jessen, Frank, et al. "Comment by European Alzheimer’s Disease Consortium (EADC) Investigators on the Negative Recommendation of the CHMP on the Marketing Authorization of Donanemab for Early Alzheimer’ S Disease. Letter to the Editor." The Journal of Prevention of Alzheimer's Disease, vol. 12, no. 8, 2025, https://doi.org/10.1016/j.tjpad.2025.100259.